How Checkpoint Inhibitors Are Impacting Treatment Algorithms In mCRC

Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, How Checkpoint Inhibitors Are Impacting Treatment Algorithms In mCRC. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com